Technology
Health
Pharmaceutical

Anika Therapeutics

$40.77
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.43 (1.07%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell ANIK and other stocks, options, ETFs, and crypto commission-free!

About ANIK

Anika Therapeutics Inc. Common Stock, also called Anika Therapeutics, is an orthopedic and regenerative medicines company, which develops, manufactures and commercializes therapeutic products for pain management, tissue regeneration, and wound healing. Read More Its products are based on hyaluronic acid, a natural chemical occurring, biocompatible polymer found throughout the body. It offers therapeutic products which include orthobiologics, dermal, ophthalmic, surgical, ophthalmic and veterinary. The company was founded in 1992 and is headquartered in Bedford, MA.

Employees
133
Headquarters
Bedford, Massachusetts
Founded
1992
Market Cap
573.39M
Price-Earnings Ratio
19.75
Dividend Yield
0.00
Average Volume
144.41K
High Today
$41.30
Low Today
$40.07
Open Price
$40.21
Volume
119.12K
52 Week High
$44.95
52 Week Low
$29.01

Collections

Technology
Health
Pharmaceutical
Therapy
US
North America

ANIK News

Yahoo FinanceJun 17

The global hyaluronic acid market size is expected to reach USD 15.25 billion by 2026 registering a CAGR of 7.8%

89

ANIK Earnings

-$0.46
-$0.08
$0.30
$0.68
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Available Jul 24, After Hours

More ANIK News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.